Article Text

PDF
Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation
  1. M Vermeulen1,
  2. M H J van Oers2
  1. 1
    Department of Neurology (H2-227), Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands
  2. 2
    Department of Haematology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands
  1. Dr M Vermeulen, Department of Neurology (H2-227), Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, the Netherlands; m.vermeulen{at}amc.uva.nl

Abstract

We describe relapse of chronic inflammatory demyelinating polyneuropathy in a patient who had been in remission for 5 years after treatment with autologous stem cell transplantation. Before the transplant, he needed higher doses of immunosuppressive treatment than are now necessary to maintain his improved condition. He now receives intravenous immunoglobulins at monthly intervals.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Abbreviations:
    ASCT
    autologous stem cell transplantation
    CIDP
    chronic inflammatory demyelinating polyneuropathy
    MS
    multiple sclerosis

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.